Modelling the interaction between danoprevir and mericitabine in the treatment of chronic HCV infection. (2016)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3851/imp3006
PubMed Identifier: 26555159
Publication URI: http://europepmc.org/abstract/MED/26555159
Type: Journal Article/Review
Volume: 21
Parent Publication: Antiviral therapy
Issue: 4
ISSN: 1359-6535